Literature DB >> 18701631

Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction.

Yuichiro Izumi1, Yushi Nakayama, Hasiyet Memetimin, Takeaki Inoue, Yukimasa Kohda, Hiroshi Nonoguchi, Kimio Tomita.   

Abstract

Arginine vasopressin (AVP) and hypertonicity in the renal medulla play a major role in the urine concentration mechanism. Previously, we showed that rat vasopressin V2 receptor (rV2R) promoter activity was increased by vasopressin V2R stimulation and decreased by vasopressin V1a receptor (V1aR) stimulation in a LLC-PK1 cell line stably expressing rat V1aR (LLC-PK1/rV1aR). In the present study, we investigated the effects of hypertonicity on the rV2R promoter activity and on the suppression of rV2R promoter activity by V1aR stimulation in LLC-PK1/rV1aR cells. rV2R promoter activity was increased in NaCl- or mannitol-induced hypertonicity. The hypertonicity-responsive site in the rV2R promoter region was limited to 10 bp, including the Sp1 motif. The increase of V2R promoter activity by hypertonicity was significantly inhibited by a JNK inhibitor (SP600125) and PKA inhibitor (H89). In contrast, rV2R promoter activity was remarkably suppressed by V1aR stimulation in the hypertonic condition rather than in the isotonic condition. The AVP-stimulated intracellular Ca2+ concentration was increased in the hypertonic condition, suggesting the functional activation of V1aR by hypertonicity. In conclusion, 1) V2R promoter activity is increased by hypertonicity via the JNK and PKA pathways, 2) suppression of V2R expression by the V1aR-Ca2+ pathway is enhanced by hypertonicity, and 3) hypertonicity enhances the V1aR-Ca2+ pathway. The counteractivity of V2R and V1aR could be required to maintain minimum urine volume in the dehydrated state.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18701631     DOI: 10.1152/ajprenal.00119.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  5 in total

1.  Site-1 protease-derived soluble (pro)renin receptor targets vasopressin receptor 2 to enhance urine concentrating capability.

Authors:  Fei Wang; Chuanming Xu; Renfei Luo; Kexin Peng; Nirupama Ramkumar; Shiying Xie; Xiaohan Lu; Long Zhao; Chang-Jiang Zuo; Donald E Kohan; Tianxin Yang
Journal:  JCI Insight       Date:  2019-04-04

2.  Decreased expression of aquaporin 2 in the collecting duct of mice lacking the vasopressin V1a receptor.

Authors:  Yukiko Yasuoka; Mizuka Kobayashi; Yuichi Sato; Hiroshi Nonoguchi; Akito Tanoue; Hirotsugu Okamoto; Katsumasa Kawahara
Journal:  Clin Exp Nephrol       Date:  2012-09-12       Impact factor: 2.801

3.  Epigenetic regulation of arginine vasopressin receptor 2 expression by PAX2 and Pax transcription interacting protein.

Authors:  Saji Abraham; Raghavendra Paknikar; Samina Bhumbra; Danny Luan; Madhusudan Venkatareddy; Christopher O'Connor; Markus Bitzer; Robert A Fenton; Toby Hurd; Puneet Garg; Sanjeevkumar R Patel
Journal:  Am J Physiol Renal Physiol       Date:  2021-02-01

4.  Vasopressin receptors V1a and V2 are not osmosensors.

Authors:  Kasper Lykke; Mette Assentoft; Robert A Fenton; Mette M Rosenkilde; Nanna MacAulay
Journal:  Physiol Rep       Date:  2015-08

5.  dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells.

Authors:  Mariangela Centrone; Mariagrazia D'Agostino; Marianna Ranieri; Maria Grazia Mola; Pinuccia Faviana; Piero Vincenzo Lippolis; Domenico Alessandro Silvestris; Maria Venneri; Annarita Di Mise; Giovanna Valenti; Grazia Tamma
Journal:  Front Cell Dev Biol       Date:  2022-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.